7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 
      
    		                       
      operating activities:
    		                       
      net income
    		-27,472,000 34,538,000 -34,358,000 -49,028,000 -35,753,000 -37,897,000 -59,949,000 -48,952,000 -92,986,000 -62,414,000 -50,747,000 -17,215,000 -41,914,000 -64,458,000 -42,413,000 -18,449,000 -17,171,000 -11,052,000 -11,551,000 -65,848,000 -40,167,000 -21,143,000 -7,134,000 
      adjustments to reconcile net income to net cash from operating activities:
    		                       
      stock-based compensation expense
    		25,264,000 27,559,000 31,076,000 32,540,000 33,588,000 38,492,000 36,129,000 38,918,000 40,235,000 45,696,000 42,101,000 40,974,000 33,514,000 36,313,000 26,047,000 26,904,000 25,950,000 26,932,000 16,176,000 13,784,000    
      depreciation and amortization
    		10,297,000 7,815,000 8,022,000 8,750,000 8,964,000 8,971,000 9,194,000 9,717,000 9,372,000 9,941,000 6,482,000 6,521,000 6,156,000 6,500,000 6,191,000 5,781,000 5,696,000 4,889,000 4,752,000 3,592,000 3,313,000 3,189,000 2,845,000 
      amortization of right-of-use assets
    		1,954,000 1,836,000 1,792,000 1,814,000 1,786,000 1,929,000 2,300,000 1,989,000 2,048,000 1,936,000 2,134,000 1,951,000 1,959,000 1,944,000 1,784,000 1,543,000 1,579,000 2,298,000 1,716,000 1,285,000 1,155,000 1,071,000  
      fair value adjustments on contingent consideration
    		                       
      asset and lease impairment charges
    		                       
      realized loss on marketable securities
    		   0 2,000   3,000 0 0 1,715,000             
      other
    		-434,000 -351,000 -575,000 -48,000 62,000 65,000 444,000 -43,000 -143,000 463,000 150,000             
      changes in operating assets and liabilities:
    		                       
      accounts receivable
    		6,629,000 2,592,000 35,325,000 -4,370,000 7,683,000 122,000 23,516,000 -10,974,000 -16,165,000 -9,753,000 26,279,000 -20,621,000 -7,352,000 297,000 8,728,000 -6,825,000 -19,392,000 -1,635,000 -6,189,000 -13,300,000 8,125,000 2,521,000 -7,222,000 
      other receivables
    		16,276,000                       
      inventory
    		7,287,000 7,026,000 8,058,000 9,619,000 -4,262,000 -5,197,000 -9,937,000 7,614,000 2,568,000 -1,862,000 -449,000 -1,431,000 -8,660,000 -7,365,000 -3,736,000 -8,783,000 -7,134,000 -5,601,000 -8,614,000 -3,360,000 -2,401,000 -4,087,000 -1,964,000 
      prepaid expenses and other current assets
    		1,383,000 4,789,000 -5,530,000 -2,597,000 1,594,000 1,131,000 -2,029,000 1,217,000 -1,523,000 2,130,000 -4,253,000 -2,038,000 2,891,000 -1,475,000 -3,873,000 167,000 -150,000 514,000 -1,584,000 -1,657,000 -2,307,000 601,000 -779,000 
      other noncurrent assets
    		-149,000 125,000 2,314,000 766,000 283,000 -2,349,000 216,000 -388,000 17,783,000 -7,603,000 -10,470,000 514,000 296,000 -42,000 157,000         
      accounts payable
    		-196,000 6,035,000 -2,547,000 -13,398,000 4,339,000 1,122,000 4,583,000 -3,206,000 -4,125,000 2,095,000 -781,000 -224,000 -4,180,000 7,387,000 2,875,000 -1,107,000 2,480,000 -1,174,000 10,885,000 -497,000 -2,157,000 -653,000 2,215,000 
      accrued compensation and other related benefits
    		10,101,000 3,928,000 -11,745,000 3,729,000 9,885,000 -580,000 -9,380,000 1,532,000 6,144,000 4,816,000 -15,129,000 4,277,000 4,844,000 5,276,000 -13,283,000 4,469,000 6,138,000 4,428,000 1,302,000 811,000 -8,288,000 6,191,000 4,454,000 
      deferred revenue
    		-190,000 -805,000 347,000 3,067,000 2,310,000 3,712,000 2,120,000 4,295,000 3,752,000 1,834,000 1,051,000 1,505,000 178,000 1,437,000 230,000 314,000 269,000 604,000 348,000 406,000 21,000 471,000 -153,000 
      accrued expenses and other current liabilities
    		-7,048,000 -7,220,000 4,329,000 4,399,000 -5,008,000 547,000 -12,674,000 19,148,000 8,659,000 655,000 -161,000 469,000 7,789,000 -1,381,000 -3,541,000 1,672,000 3,985,000 702,000 -7,232,000 6,364,000 -1,485,000 4,585,000 3,221,000 
      operating lease liability
    		-2,604,000 -2,355,000 -2,631,000 -2,721,000 -4,164,000 -2,638,000 -2,961,000 -2,807,000 -1,324,000 -2,232,000 -2,308,000 -1,857,000 -2,385,000 -1,824,000 -357,000 29,000 672,000 -1,746,000 -1,424,000 -1,107,000 -704,000 -1,282,000  
      other noncurrent liabilities
    		281,000 680,000 360,000 130,000 332,000 65,000 249,000 635,000 401,000 -13,000 261,000 61,000 -3,360,000 151,000 206,000 -620,000 228,000 -775,000 -3,538,000 1,125,000 1,415,000 -5,742,000 367,000 
      net cash from operating activities
    		43,214,000 17,708,000 34,351,000 -6,748,000 21,641,000 7,496,000 -15,725,000 25,758,000 -25,304,000 -11,526,000 -4,125,000 13,723,000 -9,564,000 -16,963,000 -20,802,000 5,805,000 -26,216,000 3,120,000 -4,082,000 -55,629,000 -29,518,000 -2,576,000 6,700,000 
      capex
    		-853,000 -1,675,000 -1,495,000 -2,716,000 -4,387,000 -3,325,000 -1,011,000 -3,450,000 -21,653,000 -46,707,000 26,109,000 -39,734,000 -33,961,000 -15,563,000 -13,113,000 -27,618,000 -20,227,000 -14,568,000 -38,865,000 -509,000 -7,096,000 -5,268,000 -8,575,000 
      free cash flows
    		42,361,000 16,033,000 32,856,000 -9,464,000 17,254,000 4,171,000 -16,736,000 22,308,000 -46,957,000 -58,233,000 21,984,000 -26,011,000 -43,525,000 -32,526,000 -33,915,000 -21,813,000 -46,443,000 -11,448,000 -42,947,000 -56,138,000 -36,614,000 -7,844,000 -1,875,000 
      investing activities:
    		                       
      purchases of intangible assets
    		    0                   
      asset acquisition
    		                       
      purchases of property and equipment
    		-687,000 -1,578,000 -1,893,000 -2,716,000 -3,889,000 -2,878,000 -2,910,000 -3,450,000 -15,236,000 -25,356,000 -4,559,000 -39,734,000 -36,572,000 -27,219,000 -28,136,000 -27,618,000 -20,227,000 -14,568,000 -38,865,000 -509,000 -6,739,000 -8,079,000 -6,556,000 
      purchases of marketable securities
    		-49,498,000                       
      proceeds from sales of marketable securities
    		   0 271,000 3,017,000 568,000 4,054,000 1,190,000 1,605,000 93,342,000 7,716,000 8,708,000           
      proceeds from maturities of marketable securities
    		50,000,000   0 0 12,808,000 12,974,000 12,494,000 19,146,000 19,289,000 31,896,000 1,346,000 8,058,000           
      net cash from investing activities
    		-8,801,000 -939,000 -1,893,000 -51,592,000 -3,618,000 11,947,000 10,632,000 13,098,000 4,900,000 -4,462,000 119,956,000 -33,172,000 -32,630,000 -27,527,000 -257,558,000 -27,618,000 -20,227,000 -14,568,000 -44,316,000 -1,310,000 -6,739,000 -8,079,000 -6,581,000 
      financing activities:
    		                       
      issuance of common stock from exercise of stock options and employee stock purchase plan purchases
    		617,000 3,522,000 422,000 4,517,000 156,000   5,613,000 4,374,000   5,001,000 2,039,000   8,903,000 6,683,000 16,193,000 8,546,000 3,921,000    
      net cash from financing activities
    		617,000 3,522,000 422,000 4,517,000 156,000 4,603,000 1,638,000 5,613,000 4,374,000 7,096,000 -3,414,000 5,001,000 2,039,000 6,360,000 2,417,000 8,903,000 6,683,000 16,193,000 3,518,000 486,968,000 8,051,000 -33,819,000 -1,107,000 
      effect of exchange rates changes on cash, cash equivalents, and restricted cash
    		                       
      net increase in cash, cash equivalents, and restricted cash
    		       44,546,000 -16,115,000 -8,941,000 112,441,000     -12,992,000      -44,590,000 -996,000 
      cash, cash equivalents, and restricted cash at beginning of period
    		  344,067,000  0    0 0 227,353,000  0 0 596,073,000  0 0 688,644,000 0 0 476,493,000  
      cash, cash equivalents, and restricted cash at end of period
    		  377,061,000  18,335,000    -16,115,000 -8,941,000 339,794,000  -40,240,000 -38,322,000 320,112,000  -39,643,000 4,751,000 643,957,000 430,008,000 -28,213,000 431,903,000  
      supplemental disclosures of cash flow information:
    		                       
      cash paid for taxes
    		617,000 856,000 462,000 778,000 2,823,000 1,079,000 961,000 476,000 599,000 1,305,000 2,547,000 276,000 330,000 419,000 2,900,000 342,000 480,000 1,016,000 6,822,000 64,000 43,000 117,000 0 
      noncash investing and financing activities:
    		                       
      purchases of property and equipment included in accounts payable and accrued expenses and other current liabilities
    		-166,000 -97,000 398,000  -498,000 -447,000 1,899,000  -6,417,000 -21,351,000 30,668,000  2,611,000 11,656,000 15,023,000      -357,000 2,811,000 -2,019,000 
      right-of-use assets obtained in exchange for new operating lease liabilities
    		3,055,000       -652,000 277,000 0 6,893,000  0 0 16,562,000      -76,000 7,634,000  
      common stock issued for acquisition of assets
    		                       
      lease and asset impairment charges
    		 0 114,000 600,000 0 0 2,454,000                 
      effect of exchange rates changes on cash, cash equivalents
    		 360,000 114,000                     
      net increase in cash and cash equivalents
    		 20,651,000 32,994,000  18,335,000 24,043,000 -3,503,000                 
      cash, cash equivalents at beginning of period
    		                       
      cash, cash equivalents at end of period
    		                       
      purchase of intangible assets
    		         0 -723,000             
      acquisition of business, net of cash acquired
    		           -2,500,000    0 0 0 -5,451,000     
      purchase of marketable securities
    		           0 -11,324,000 -29,218,000 -242,329,000         
      payments on technology license financing arrangement
    		                       
      effect of exchange rate changes on cash, cash equivalents, and restricted cash
    		   -269,000 156,000 -3,000 -48,000 77,000 -85,000 -49,000 24,000 251,000            
      cash, cash equivalents, and restricted cash at beginning of year
    		                       
      cash, cash equivalents, and restricted cash at end of year
    		                       
      cash paid for interest
    		       0 0 0 436,000 0 0 0 841,000 0 0 0 1,222,000 0 0 1,670,000 528,000 
      noncash investing and financing activities
    		                       
      purchases of property and equipment included in accounts payable, accrued expenses and other current liabilities
    		                       
      payments on financing arrangement
    		        0 0 -5,814,000  0 0 -5,409,000  0 0 -5,028,000 0 0 -5,846,000  
      issuance of common stock from exercise of stock options
    		      1,638,000    2,400,000    7,826,000         
      cash and cash equivalents at beginning of period
    		      359,284,000                 
      cash and cash equivalents at end of period
    		      355,781,000                 
      asset impairment charges
    		                       
      accrued contingent liabilities
    		               0 -29,497,000 -15,352,000 676,000 2,382,000 1,862,000 4,656,000 6,157,000 
      contingent consideration payable related to business acquisition
    		                       
      lease impairment charges
    		        0               
      contingent consideration payable from business acquisition
    		            0 0 1,500,000         
      loss on disposal of property and equipment
    		           631,000 450,000   13,000 0 36,000 30,000    0 
      loss on extinguishment of debt
    		                   0 0 1,521,000  
      amortization of premium and accretion of discount on marketable securities
    		           206,000 210,000 272,000 183,000         
      class a common stock issued for in-process research and development
    		                       
      accretion of discount on term loan
    		                   0 0 17,000 29,000 
      acquisition of intangible assets
    		                       
      payments on term loans
    		                   0 0 -31,256,000  
      proceeds from issuance of common stock upon initial and follow-on public offerings, net of issuance costs
    		                       
      net decrease in cash, cash equivalents, and restricted cash
    		            -40,240,000 -38,322,000 -275,961,000   4,751,000 -44,687,000     
      effect of exchange rates on changes in cash, cash equivalents, and restricted cash
    		             -192,000 -18,000 -82,000 117,000 6,000 193,000 -21,000 -7,000 -116,000 -8,000 
      proceeds from sales and maturities of marketable securities
    		              12,907,000         
      deferred rent, noncurrent
    		                      -111,000 
      proceeds from borrowings under revolver
    		                      0 
      payments on borrowings under revolver
    		                      0 
      other assets
    		                131,000 52,000 165,000 392,000 -1,756,000 -1,210,000 -300,000 
      proceeds from issuance of common stock from follow-on public offering, net of issuance costs
    		                       
      proceeds from issuance of common stock upon initial and follow-on public offering, net of issuance costs
    		                       
      deferred offering costs
    		                       
      deferred offering costs in accounts payable and accrued expenses and other current liabilities
    		                       
      debt discount in accrued expenses and other current liabilities
    		                       
      stock-based compensation
    		                     6,718,000 5,075,000 
      proceeds from issuance of common stock upon exercise of stock options
    		                     3,283,000 748,000 
      proceeds from term loans
    		                       
      payments on capital lease obligations
    		                       
      proceeds from issuance of common stock upon initial public offering, net of issuance costs
    		                      -1,855,000 
      proceeds from issuance of preferred stock, net of issuance costs
    		                       
      repurchase of unvested common stock related to early exercised shares
    		                       
      conversion of convertible preferred stock into common stock upon initial public offering
    		                      0 
      purchase of technology licenses under financing arrangement
    		                       
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.